INTERVENTIONALRESULTS AVAILABLE2021-005331-23

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients with Prader-Willi Syndrome

Hyperphagia related behavior associated with Prader-Willi Syndrome

Locally preserved from EU Clinical Trials Register (EudraCT)Open EU Clinical Trials Register (EudraCT)last source update not reported

What this record can show

Registry results are available

Registry submitter results are candidate evidence, not independent verification.

Registry facts

Linked local records

Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.

No published condition report matched.

No governed compound link was found.

No exact medicine-name link was found.

Interventions

No structured intervention was reported.

Source-reported results

Registry submitter results are candidate evidence, not independent verification.

Structured result tables are not available in this local record. Check the source record for details.

Eligibility

No structured eligibility criteria were reported.

Publications

No exact PMID-linked public article is currently readable locally.

Snapshot provenance